Accelerating Science Feature
Frontiers in immuno-oncology and personalized medicine
Unlock the potential of the immune system in the fight against cancer with advancements in immuno-oncology and precision medicine.
Explore the latest therapeutic developments using groundbreaking discoveries such as immune checkpoint inhibitors, CAR-T cell therapy, adoptive cell transfer, neoantigen targeting, and more. Hear from experts researching the role of tumor-infiltrating lymphocytes (TILs), natural killer (NK) cells, and monoclonal antibodies (mAbs) in enhancing immune response, and see how these insights are helping to develop personalized immunotherapies and revolutionize cancer treatment.
Gain insight into the TME of solid tumors with a predefined, plug-and-play antibody panel
Save panel development time and analyze a wide range of tumor types with the versatile REAscreen™ Immuno-oncology Panel from Miltenyi Biotec to enable faster discovery and further development of predictive and prognostic biomarkers.
Download resource
Decode the TME for biomarker discovery and immunotherapy insights
See how advanced technologies from Raybiotech help unlock critical insights into tumor biology by addressing key areas such as biomarker discovery, tumor-immune interactions, personalized immunotherapy, and data integration.
Watch webinar
Drive your translational research with multiplex immunofluorescence
Dr. Tom Lund, Scientific Lead of the Integrated Pathology Unit and Head of Digital Pathology for the Centre of Translational Immunotherapy in London, shares insight into his team’s innovative immunotherapy research and the role of the PhenoImager® HT 2.0 Instrument from Akoya Biosciences.
Read article
How antibody-drug conjugates are advancing cancer treatment
Gain insight into what makes ADCs a game-changer in oncology, the key manufacturing challenges, and what the future may hold for this evolving therapeutic approach.
Watch video series
Accelerate neoantigen-based immunotherapy development for cancer treatment
With this free eBook, learn how to overcome challenges in neoantigen-based immunotherapy development and leverage synthetic peptides for cancer treatment.
Download eBook
Unraveling the tumor microenvironment of pancreatic cancer
Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy.
Read article
Explore the rest of our Accelerating Cancer Research feature
